Search research articles
Contact Us
Filters
Showing results (41-50 of 101) with videos related to
Page
of 11
Sort By:
British Journal of Haematology
|
February 7, 2024
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients
Vincent Alcazer, Stéphane Morisset, Delphine Rea, et al.
Transfusion
|
February 17, 2007
Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery
Jean-Pierre Marolleau, Valérie Vanneaux, Delphine Rea, et al.
Blood
|
August 17, 2012
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Jorge Cortes, Jeff H Lipton, Delphine Rea, et al.
Blood
|
September 16, 2006
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Philippe Rousselot, Francoise Huguet, Delphine Rea, et al.
European Journal of Immunology
|
February 10, 2004
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses
Nicolle H R Litjens, Mirjam Rademaker, Bep Ravensbergen, et al.
Haematologica
|
August 11, 2018
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
Timothy P Hughes, Pierre Laneuville, Philippe Rousselot, et al.
Transfusion
|
March 15, 2006
Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34(+) cell quantification
Jerome Larghero, Delphine Rea, Yves Brossard, et al.
Blood
|
October 26, 2013
Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase
Clémence Roux, Franck-Emmanuel Nicolini, Delphine Rea, et al.
American Journal of Hematology
|
July 29, 2018
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
Zdenek Racil, Eva Koritakova, Tomasz Sacha, et al.
Transfusion
|
March 15, 2006
ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery
Jerome Larghero, Delphine Rea, Helene Esperou, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 101) with videos related to
Sort By:
Page
of 11
British Journal of Haematology
|
February 7, 2024
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients
Vincent Alcazer, Stéphane Morisset, Delphine Rea, et al.
Transfusion
|
February 17, 2007
Quantification of nucleated red blood cells in allogeneic marrow graft and impact of processing on recovery
Jean-Pierre Marolleau, Valérie Vanneaux, Delphine Rea, et al.
Blood
|
August 17, 2012
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
Jorge Cortes, Jeff H Lipton, Delphine Rea, et al.
Blood
|
September 16, 2006
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
Philippe Rousselot, Francoise Huguet, Delphine Rea, et al.
European Journal of Immunology
|
February 10, 2004
Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses
Nicolle H R Litjens, Mirjam Rademaker, Bep Ravensbergen, et al.
Haematologica
|
August 11, 2018
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemia
Timothy P Hughes, Pierre Laneuville, Philippe Rousselot, et al.
Transfusion
|
March 15, 2006
Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34(+) cell quantification
Jerome Larghero, Delphine Rea, Yves Brossard, et al.
Blood
|
October 26, 2013
Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase
Clémence Roux, Franck-Emmanuel Nicolini, Delphine Rea, et al.
American Journal of Hematology
|
July 29, 2018
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
Zdenek Racil, Eva Koritakova, Tomasz Sacha, et al.
Transfusion
|
March 15, 2006
ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery
Jerome Larghero, Delphine Rea, Helene Esperou, et al.
Page
of 11